Source: European Respiratory Journal. Unidade: FM
Subjects: HIPERTENSÃO PULMONAR, MORTALIDADE, ESTUDOS MULTICÊNTRICOS
ABNT
HOEPER, Marius M. et al. Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies. European Respiratory Journal, v. 65, n. 5, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/88287. Acesso em: 24 abr. 2026.APA
Hoeper, M. M., Gomberg-Maitland, M., Badesch, D. B., Gibbs, J. S. R., Gruenig, E., Kopec, G., et al. (2025). Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies. European Respiratory Journal, 65( 5). doi:10.1183/13993003.01424-2024NLM
Hoeper MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, Gruenig E, Kopec G, Mclaughlin VV, Meyer G, Olsson KM, Souza R de. Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies [Internet]. European Respiratory Journal. 2025 ; 65( 5):[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88287Vancouver
Hoeper MM, Gomberg-Maitland M, Badesch DB, Gibbs JSR, Gruenig E, Kopec G, Mclaughlin VV, Meyer G, Olsson KM, Souza R de. Efficacy and safety of the activin signalling inhibitor, sotatercept, in a pooled analysis of PULSAR and STELLAR studies [Internet]. European Respiratory Journal. 2025 ; 65( 5):[citado 2026 abr. 24 ] Available from: https://observatorio.fm.usp.br/handle/OPI/88287
